Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Unilever nearing £230m deal to buy refillable cosmetics maker Wild - report

(Sharecast News) - Consumer goods giant Unilever is reportedly closing in on a £230m deal to snap up Wild, a premium producer of refillable personal care products backed by the founders of Innocent Drinks. According to Sky News, Unilever has agreed the terms of a transaction to buy Wild from its founders and early-stage investors. Industry sources said a deal could be announced within weeks.

If confirmed, it would be one of Unilever's most significant acquisitions in the personal care space for some years, and comes as chief executive Hein Schumacher accelerates efforts to revamp its portfolio, Sky said.

It was understood that Unilever has been drawn to the Wild business because of both its premium brand positioning and its commitment to sustainability.

Wild - which was founded by Charlie Bowes-Lyon and Freddy Ward - sells refillable natural deodorants, lip balms, body washes and hand washes direct to consumers.

The sale price of up to £230m is understood to include a sizeable earnout for the founders, Sky said.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.